Connect with us

Published

on

Daniel Erichsen, founder of the Sleep Coach School

Daniel Erichsen

Daniel Erichsen spent about a decade as a sleep doctor, primarily seeing patients who were struggling with sleep apnea and insomnia.

His career took a dramatic turn early last year, when he was fired from his hospital job in Oregon. Erichsen, 42, had stopped prescribing sleeping pills to patients and for the most part refused to refer them for expensive and time-consuming tests that he deemed pointless.

Erichsen didn’t suddenly turn anti-medicine. Growing up in Sweden, the son of a doctor and a nurse, he knew what he wanted to do from a very early age. He studied at the Karolinska Institute, a medical school in Stockholm, moved to New York for his residency in 2007 and then did a fellowship in sleep medicine at the University of Chicago.

But after years spent listening to patients describe their struggles with sleeplessness and their desperate efforts to find the supplement, essential oil, herbal tea, yoga practice or prescription pill that would fix their issue, Erichsen concluded that the patients weren’t the problem. Rather, the problem was the ways they were being treated.

“This wasn’t working for people,” Erichsen said in an interview from his home in Eugene, Oregon. “I was not a fit anymore. The system was not a fit for me.”

Insomnia is a big business. According to market research firm Imarc, the global insomnia market will hit $5.1 billion this year and climb to $6.1 billion by 2028. That includes spending on prescription drugs, over-the-counter sleep aids, medical devices and various types of therapy.

Imarc said in its report that the Covid-19 pandemic, which hit the U.S. in early 2020, “generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations” and acted “as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth.”

Even before the pandemic, the tech industry had found plenty of ways to capitalize on sleep and humans’ desire to optimize it. Sleep trackers are everywhere, embedded in the Apple Watch and Fitbit devices. There’s the smart ring from Oura, which said in April that it raised a funding round at a $2.55 billion valuation, less than a month after selling its 1 millionth ring.

Oura Ring CEO on growth of wearables during the pandemic

Numerous meditation apps like Calm, Headspace and Breethe contain content designed to help people sleep.

Other apps, including some backed by venture capital firms, promote cognitive behavioral therapy for insomnia, or CBT-I. That therapy is meant to change the way people think about sleep and incorporates behavior changes like sleep restriction and stimulus control. Participants are urged to get out of bed after being awake for a certain amount of time.

CBT-I apps include Sleep Reset, developed by Simple Habit, and Dawn Health, which announced this month that it raised “strategic funding” from early stage firm Kindred Ventures.

Dawn said in its press release that insomnia affects 49 million Americans and results in $84 billion in health-care costs and $100 billion in “safety incidents and lost productivity.” CBT-I programs usually last two to three months. Dawn charges $249 for the first three months, while Sleep Reset currently costs $225 for the same amount of time.

What if insomnia is a phobia?

Erichsen said he had tried CBT-I with patients during his years as a physician, and it would sometimes work. Other times a patient would start the program and he’d never hear from the person again. For some people, strict sleep restriction imposed an important element of structure in their lives. For others, it created added anxiety and worry — another failed effort to find a cure.

After listening to hundreds of stories from people with sleep struggles, Erichsen came to believe that the medical industry was misclassifying insomnia as a sleep disorder, grouping it with depression, anxiety and psychotic disorders.

Erichsen had come to see it differently. People who showed up in his clinic were scared. They’d experienced a few bad nights of sleep from a sickness or stressful event. When normal sleep didn’t return, they fell into full-blown panic mode. They thought something was deeply wrong and that they’d forgotten how to sleep. The dark abyss of the internet contained limitless stories about the long-term health problems awaiting them if normal sleep didn’t return.

Fear was the common denominator. So instead of calling insomnia a disorder, Erichsen prefers to describe it as a phobia, thus reframing how it should be addressed.

“Think of the implications,” Erichsen said. “When we say, ‘Oh you have to take medications to sleep or exercise or do all these things,’ you’re actually worsening the phobia.”

After being removed from his medical practice, last year Erichsen became a full-time sleep coach and evangelist for changing the way people think about sleep. He loads up his YouTube channel, The Sleep Coach School, with educational content several days a week and releases the same discussions in podcast form. He also has an app called BedTyme, which combines educational lessons with personalized coaching.

Apart from the free content he puts out to the public, none of this comes cheap. A group-oriented program called “Insomnia Immunity” costs $259 a month. A 45-minute call with Erichsen runs for $289 (or $169 for a call with another coach) and BedTyme costs $330 a month.

Mental health challenges are creating a second pandemic: Headspace

Erichsen hasn’t raised any outside funding, and said the business is hard to run profitably because it doesn’t scale like a tech company. There’s a lot of one-on-one coaching for each client.

“It’s very involved work,” Erichsen said.

The objective, Erichsen said, is to help people find their way without needing month after month of costly assistance. Within two to four months, most clients are ready to go it alone, he said.

“We celebrate when somebody graduates, and says ‘I don’t need you anymore, I can be my own coach,'” Erichsen said. “From a business perspective, that’s not a problem. They become an ambassador and we find somebody else to work with.”

Erichsen acknowledges that his approach is quite nascent. His YouTube channel has a modest following of 7,000, up from 4,000 at the start of the year, and his coaching practice is small enough that he doesn’t think the sleep medicine world is aware he exists.

“My friends who are doctors think it’s nice, but they don’t fully understand it,” Erichsen said. “We’re so far off the radar, that nobody in the medical establishment knows what we’re doing.”

CNBC reached out to another sleep expert to get an industry perspective on Erichsen’s approach. Michael Breus is a clinical psychologist and fellow of the American Academy of Sleep Medicine. He runs The Sleep Doctor website, which was launched in 2008 and describes itself as “a leading authority in the field of sleep health.”

Breus took a look at Erichsen’s website and offered his thoughts via email.

“This sounds like a disaster,” he wrote, adding that Erichsen’s methods “will give many people false hope.” Breus said he gives “little to no merit” to the idea that insomnia can be best understood as a phobia. After reviewing the site, Breus said Erichsen offers no data on the effectiveness of his approach, yet he “seems to feel just fine about now marketing himself with a new method, and new theory.”

Erichsen responded by saying that while he doesn’t provide data, his YouTube channel has an “abundance of interviews with people who have found benefits with the way we approach insomnia.” He said he avoids most of the industry metrics, because they “lead to the idea that sleep can be controlled and that we should achieve a certain sleep score or number after putting in a certain amount of work.”

‘The more I chased sleep, the less I slept’

Saniya Warwaruk and her husband, Edward Warwaruk

Saniya Warwaruk

Warwaruk, 33, was coming off a year of debilitating insomnia, which she chronicled recently in a first-person story for the CBC (Canadian Broadcasting Corp.) website. In May 2021, Warwaruk had a few bad nights, waking up at 3 a.m., and was unable to get back to sleep. As the struggle persisted, she started using supplements.

“Then came the appointments — the blood work checking for tumours and hormones, the electrocardiogram, the sleep study,” she wrote. “Aggravatingly, the results showed I was perfectly healthy. Yet the more I chased after sleep, the less I slept.” 

As she described it in her TEDx talk, when she would try a new thing and it would fail, “you crank up the anxiety and the fear, which leads to more insomnia and so on and so on and so on.” She also tried CBT-I, which resulted in “the darkest days of my life,” she told CNBC in an interview.

After several months of near sleeplessness, constant anxiety and brain fog, Warwaruk, who’s married, briefly went to live with her parents in Calgary because she needed extra care. Soon after her return home, her husband stumbled upon Erichsen’s ideas online.

Watching Erichsen’s videos, Warwaruk said she quickly understood this was different. Whereas CBT-I forced her to practice sleep restriction, get out of bed if she was awake for 15 minutes in the middle of the night and avoid daytime naps, Erichsen was advocating gentler methods, designed to reduce the intensity level along the path to recovery.

She established a sleep window for herself, providing a finite period for sleep each night but without having to limit it to six or fewer hours at the start.

Warwaruk quickly started to learn that if she could train her brain that there was nothing to fear, the cycle could reverse. Instead of constantly seeking solutions, she woke up every day and lived as if she didn’t have insomnia. She exercised, hung out with friends and concentrated on her studies even if her sleep wasn’t great. She stopped trying to make sleep happen.

“No pills, no treatments, no therapies, no teas, no sleep hygiene, nothing,” she said at the TEDx event. “I was no longer to chase after sleep.” She would even watch TV shows during her middle-of-the-night wakefulness, “breaking the cardinal rule of no blue screens.” Her preference was “Seinfeld.”

That’s when she started to sleep. It wasn’t all at once, and there were speed bumps throughout her progress, but her sleep challenges were no longer paired with obsessive anxiety about not sleeping. She told her story over the course of 15 minutes to the small crowd in Alberta.

But unless you have the YouTube link for Warwaruk’s talk, you can’t find it. TED marked it as “unlisted,” so it doesn’t show up in search results. Here’s TED’s explanation, which shows up below the video:

NOTE FROM TED: Please consult a health professional and do not look to this talk for mental health advice. This talk reflects the speaker’s personal experiences and understanding of anxiety and insomnia. Therapies discussed in this talk require further scientific investigation. We’ve flagged this talk because it falls outside the content guidelines TED gives TEDx organizers.

TED didn’t respond to a request for comment.

Erichsen said TED’s action is “the first sign of friction” he’s seen in public involving his approach. While he’d prefer to have the material readily available for anyone to see, Erichsen said he understands why there would be resistance. The medical establishment has defined insomnia in particular ways, he said, and organizations like TED don’t want to risk promoting viewpoints that could be seen as anti-science.

One of his regular podcast segments is called “Talking Insomnia,” featuring people who made it through the struggle, whether using his program or another one. Earlier this year, he published a book titled, “Tales of Courage: Twenty-six first hand accounts of how insomnia ends.”

Beth Kendall teaching her online course

Beth Kendall

Warwaruk is one of the case studies in the book. Another is Beth Kendall, a 54-year-old Minneapolis native, who says she struggled with insomnia for 42 years, starting when she was 8 and her parents moved her bedroom upstairs to the attic.

Kendall’s insomnia was sporadic for decades. Through college and then her working life as a ballet dancer and flight attendant, sleep would come and go for extended spells, leaving Kendall exhausted, confused and desperate for answers. She describes the “medication merry-go-round” and how she ended up with a drawer full of every sleeping pill imaginable. Before that, there were all the teas, so many that “I could smell them right now,” she told Erichsen.

Kendall also tried CBT-I. In a blog post about why sleep restriction doesn’t work for everybody, she said the feelings of guilt and failure that followed her initial efforts made sleep even more elusive and turned her into a “walking zombie.”

“It was a bit of torture,” she said in an interview.

Before stumbling upon Erichsen a few years ago on social media, Kendall’s condition had started to improve. She was working in the mind and body space and was certified in tapping, a practice that draws on acupuncture. She started to see insomnia as a mental program, and that the coding just had to be changed.

Kendall began blogging about sleep. People would contact her because her ideas were resonating. That turned into casual coaching, and then real coaching, including work for some of the newer apps. (Kendall was my coach on an app earlier this year.)

In October, Kendall launched her own eight-week program — Mind. Body. Sleep. Every week, clients receive several short videos with lessons demystifying why insomnia happens, how our responses can perpetuate it or minimize it, and how people can learn to be OK with wakefulness, even in the middle of the night. She also includes individual coaching sessions and sends out regular emails, reminding clients that feelings of anxiousness are normal, progress is not linear and that thing that suddenly makes you jumpy at bedtime is called hyperarousal.

“The beginning of the journey is very educational, laying down the accurate knowledge,” Kendall said. “At the end of the program, I also talk about what leaving insomnia looks like and some of the patterns.”

Kendall’s message, which mirrors much of Erichsen’s teachings, is that sleep is simple, but insomnia makes it seem complex. We try to fix it by doing more and then follow failure by doing even more. But what we should do is less.

Attention is the oxygen that insomnia needs to survive. Starve it, she says, and see what begins to change.

“Sleep is a passive process that happens in the absence of effort,” she writes in one of her emails to clients. “There is nothing you need to do for it to happen.”

WATCH: Does melatonin really help you sleep?

Does melatonin really help you sleep?

Continue Reading

Technology

Shares in Chinese chipmaker SMIC drop nearly 7% after earnings miss

Published

on

By

 Shares in Chinese chipmaker SMIC drop nearly 7% after earnings miss

A logo hangs on the building of the Beijing branch of Semiconductor Manufacturing International Corporation (SMIC) on December 4, 2020 in Beijing, China.

Vcg | Visual China Group | Getty Images

Shares of Semiconductor Manufacturing International Corporation, China’s largest contract chip maker, fell nearly 7% Friday after its first-quarter earnings missed estimates.

After trading on Thursday, the company reported a first-quarter revenue of $2.24 billion, up about 28% from a year earlier. Meanwhile, profit attributable to shareholders surged 162% year on year to $188 million.

However, both figures missed LSEG mean estimates of $2.34 billion in revenue and $225.1 million in net income, as well as the company’s own forecasts.

During an earnings call Friday, an SMIC representative said the earnings missed original guidance due to “production fluctuations” which sent blended average selling prices falling. This impact is expected to extend into the second quarter, they added.

For the current quarter, the chipmaker forecasted revenue to fall 4% to 6% sequentially. Gross margin is also expected to fall within the range of 18% to 20%, compared to 22.5% in the first quarter.

Still, the first quarter saw SMIC’s wafer shipments increase by 15% from the previous quarter and by about 28% year-on-year.

In the earnings call, SMIC attributed that growth to customer shipment pull in, brought by changes in geopolitics and increased demand driven by government policies such as domestic trade-in programs and consumption subsidies.

In another positive sign for the company, its first-quarter capacity utilization— the percentage of total available manufacturing capacity that is being used at any given time— reached 89.6%, up 4.1% quarter on quarter.

Demand in China for chips is extremely strong, says Benchmark's Cody Acree

“SMIC’s nearly 90% utilization rate reflects strong domestic demand for semiconductors, likely driven by smartphone and consumer electronics production,” said Ray Wang, a Washington-based semiconductor and technology analyst, adding that the demand was also reflected in the company’s strong quarterly revenue growth.

Meanwhile, the company said in the earnings call that it is “currently in an important period of capacity construction, roll out, and continuously increasing market share.”

However, SMIC’s first-quarter research and development spending decreased to $148.9 million, down from $217 million in the previous quarter.

Amid increased demand, it will be crucial for SMIC to continue ramping up their capacity, Simon Chen, principal analyst of semiconductor manufacturing at Informa Tech told CNBC.

SMIC generates most of its revenue from older-generation semiconductors, often referred to as “mature-node” or “legacy” chips, which are commonly found in consumer electronics and industrial equipment.

The state-backed chipmaker is critical to Beijing’s ambitions to build a self-sufficient semiconductor supply chain, with the government pumping billions into such efforts. Over 84% of its first-quarter revenue was derived from customers in China.

“The localization transformation of the supply chain has been strengthened, and more manufacturing demand has shifted back domestically,” a representative said Friday.

However, chip analysts say the chipmaker’s ability to increase capacity in advance chips — used in applications that demand higher levels of computing performance and efficiency at higher yields — is limited.

This is due to U.S.-led export controls, which prevent it from accessing some of the world’s most advanced chip-making equipment from the Netherlands-based ASML. 

Nevertheless, the chipmaker appears to be making some breakthroughs. Advanced chips manufactured by SMIC have reportedly appeared in various Huawei products, notably in the Mate 60 Pro smartphone and some AI processors.

In the earnings call, the company also said it would closely monitor the potential impacts of the U.S.-China trade war on its demand, noting a lack of visibility for the second half of the year.

Phelix Lee, an equity analyst for Morningstar focused on semiconductors, told CNBC that the impacts of U.S. tariffs on SMIC are limited due to most of its revenue coming from Chinese customers.

While U.S. customers make up about 8-15% of revenue on a quarterly basis, the chips usually remain and are consumed in Chinese products and end users, he said.

“There could be some disruption to chemical, gas, and equipment supply; but the firm is working on alternatives in China and other non-U.S. regions,” he added.

SMIC’s Hong Kong-listed shares have gained over 32.23% year-to-date.

Continue Reading

Technology

Amazon adds pet prescriptions to its online pharmacy

Published

on

By

Amazon adds pet prescriptions to its online pharmacy

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. 

Smith Collection | Gado | Getty Images

Amazon is expanding its online pharmacy to fill prescription pet medications, the company announced Thursday.

The company said it has added “hundreds of commonly prescribed pet medications” to its U.S. site, ranging from flea and tick solutions to treatments for chronic conditions.

Prescriptions are purchased via Amazon’s storefront and must be approved by a veterinarian. Online pet pharmacy Vetsource will oversee the dispensing and delivery of medications, said Amazon, adding that items are typically delivered within two to six days.

Amazon launched its digital drugstore in 2020 with the added perk of discounts and free delivery for Prime members. The company has been working to speed up prescription shipments over the past year, bringing same-day delivery to a handful of U.S. cities. Last October, Amazon set a goal to make speedy medicine delivery available in nearly half of the U.S. in 2025.

The new pet medication offerings puts Amazon into more direct competition with online pet pharmacy Chewy, as well as Walmart, which offers pet prescription delivery.

Amazon Pharmacy is part of the company’s growing stable of healthcare offerings, which also includes One Medical, the primary care provider it acquired for roughly $3.9 billion in July 2022. Amazon’s online pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack.

WATCH: Amazon’s new Vulcan robot can ‘feel’ what it touches

Here's a first look at Vulcan, Amazon's new stowing robot that can feel what it touches

Continue Reading

Technology

Coinbase acquires crypto derivatives exchange Deribit for $2.9 billion

Published

on

By

Coinbase acquires crypto derivatives exchange Deribit for .9 billion

The Coinbase logo is displayed on a smartphone with stock market percentages on the background.

Omar Marques | SOPA Images | Lightrocket | Getty Images

Coinbase agreed to acquire Dubai-based Deribit, a major crypto derivatives exchange, for $2.9 billion, the largest deal in the crypto industry to date.

The company said Thursday that the cost comprises $700 million in cash and 11 million shares of Coinbase class A common stock. The transaction is expected to close by the end of the year.

Shares of Coinbase rose nearly 6%.

The acquisition positions Coinbase as an international leader in crypto derivatives by open interest and options volume, Greg Tusar, vice president of institutional product, said in a blog post – which could allow it take on big players like Binance. Coinbase operates the largest marketplace for buying and selling cryptocurrencies within the U.S., but has a smaller share of the global crypto market, where activity largely takes place on Binance.

Deribit facilitated more than $1 trillion in trading volume last year and has about $30 billion of current open interest on the platform.

“We’re excited to join forces with Coinbase to power a new era in global crypto derivatives,” Deribit CEO Luuk Strijers said in a statement. “As the leading crypto options platform, we’ve built a strong, profitable business, and this acquisition will accelerate the foundation we laid while providing traders with even more opportunities across spot, futures, perpetuals, and options – all under one trusted brand. Together with Coinbase, we’re set to shape the future of the global crypto derivatives market.”

Tusar also noted that Deribit has a “consistent track record” of generating positive adjusted EBITDA the company believes will grow as a combined entity.  

“One of the things we liked most about this deal is that it’s not just a game changer for our international expansion plans — it immediately diversifies our revenue and enhances profitability,” Tusar told CNBC.

The deal comes at a time when the crypto industry is riding regulatory tailwinds from the first ever pro-crypto White House. Support of the industry has fueled crypto M&A activity in recent weeks. In March, crypto exchange Kraken agreed to acquire NinjaTrader for $1.5 billion, and last month Ripple agreed to buy prime broker Hidden Road.

Don’t miss these cryptocurrency insights from CNBC Pro:

Continue Reading

Trending